Top compounds associated with response to ANKRD20A4


Feature Type Standardized
Nominal ANOVA
mRNA BRD-K19103580 CTRPv2 pan-cancer AAC 0.042 0.2
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.037 0.3
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC 0.06 0.3
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.047 0.3
mRNA nelarabine CTRPv2 pan-cancer AAC -0.043 0.3
mRNA fulvestrant CTRPv2 pan-cancer AAC -0.09 0.3
mRNA YL54 CTRPv2 pan-cancer AAC -0.043 0.3
mRNA AZD4547 CTRPv2 pan-cancer AAC -0.042 0.3
Download CSV